IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Horizon Pharma Financing

Q4 2015 vs Q1 2016

Comparing institutional holders between quarters

Quarters

Q1 2016Q4 2015
CompareDetailedHistoricalFundsOptionsShort Interest13D/13GPeersTargetingTrading SummaryProfile
Advent Capital Management
UNCHANGED
Shares3,750,000 from 3,750,000
Change0 (0%)
Value$3.3K (-$19)
Filed 2016-05-13
Status
Advent Capital Management
UNCHANGED3,750,0003,750,00000%$3.3K$3.3K-$192016-05-13
Showing 1 of 1 institutions